No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

The CDC declared the end of its emergency response to H5N1 avian flu as a health threat to humans, David Murray writes.

Phase 1/2 H5 avian flu vaccine study shows positive interim results. Company has been notified that HHS will terminate Moderna’s award for late-stage development of pre-pandemic influenza vaccines.

Moderna said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot for the virus in a late-stage trial. The positive data pave the way for ...

Moderna had already started a Phase 1/2 trial of its bird flu (H5N1) vaccine and reported strong early results. (HealthDay News) — The U.S. government has canceled a $600 million contract with ...

The topic recently made its way back into headlines when Moderna announced that the Trump administration was canceling a $766 million contract to develop a bird flu vaccine for humans.

Phase 1/2 H5 avian flu vaccine study shows positive interim results. Company has been notified that HHS will terminate Moderna’s award for late-stage development of pre-pandemic influenza vaccines.

Moderna said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot for the virus in a late-stage trial.